Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
EMERYVILLE, Calif., May 23, 2014 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) today announced that it has priced $75 million aggregate principal amount of 6.50% Convertible Senior Notes due 2019...
-
EMERYVILLE, Calif., May 22, 2014 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leading renewable chemicals and fuels company, today announced that it proposes to offer $75 million aggregate...
-
Strong operating performance with combined inflows from product sales and collaboration inflows of $17.9 million On a GAAP basis, net income of $16.4 million, or $0.21 per share on a basic...
-
GENEVA, May 7, 2014 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) has completed the Roundtable on Sustainable Biomaterials (RSB) certification process and has earned one of the most respected...
-
SAO PAULO, Brazil, April 30, 2014 (GLOBE NEWSWIRE) -- A group of the world's leading industrial biotechnology companies, including Amyris (Nasdaq:AMRS), joined forces yesterday to form the Brazilian...
-
EMERYVILLE, Calif., April 23, 2014 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the first quarter ended March 31, 2014 after market close on Thursday, May 8,...
-
EMERYVILLE, Calif., April 16, 2014 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the leading synthetic biology innovator and renewable products company, today announced its industrial fermentation...
-
EMERYVILLE, Calif., April 4, 2014 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biology innovator and renewable products company, today announced it has begun selling...
-
EMERYVILLE, Calif., April 3, 2014 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) announced that it is entering into a collaborative research and development agreement with BASF SE (XETRA:BAS). Under...
-
EMERYVILLE, Calif. and TOKYO, March 31, 2014 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the leading synthetic biology innovator and renewable products company, and Kuraray Co., Ltd. (TSE:3405), a...